Item 3. Source and Amount of Funds or Other Consideration.
See Item 4 of this Schedule 13D, which information is incorporated herein by reference.
Item 4. Purpose of Transaction.
On March 12, 2021, certain of the Issuer’s initial stockholders purchased an aggregate of 5,750,000 shares of the Issuer’s Class B common stock, par value $0.0001 per share (“Class B Common Stock”) for an aggregate purchase price of $25,000, or approximately $0.004 per share (consisting of 5,630,000 shares of Class B Common Stock purchased by the Sponsor and 40,000 shares of Class B Common Stock purchased by three of the Issuer’s independent directors). On March 19, 2021, the Sponsor transferred 40,000 shares of Class B Common Stock to the fourth independent director of the Issuer at the Sponsor’s original purchase price. In connection with the Issuer’s Initial Public Offering (the “IPO”), the Sponsor entered into investment agreements with each of the Issuer’s anchor investors on October 4, 2021 pursuant to which such anchor investors purchased in the aggregate 1,450,758 shares of Class B Common Stock from the Sponsor at the Sponsor’s original purchase price. Such shares of Class B Common Stock would automatically convert into shares of Class A Common Stock at the time of the Issuer’s initial business combination, on a one-for-one basis, subject to adjustment as set forth in the Issuer’s registration statement on Form S-1.
On October 4, 2023, the Issuer consummated its IPO of 23,000,000 units, each consisting of one share of Class A Common Stock and one-half of one warrant to purchase one share of Class A Common Stock for $11.50 per share, which included the full exercise of the underwriters’ over-allotment option.
In a private placement (the “Private Placement”) that occurred simultaneously with the consummation of the IPO, the Sponsor purchased an aggregate of 6,400,000 warrants (“Private Placement Warrants”) at $1.50 per Private Placement Warrant, or an aggregate purchase price of $9,600,000. Such Private Placement Warrants will become exercisable on the later of: (i) 30 days after the completion of the Issuer’s initial business combination and (ii) 12 months from the closing of the Issuer’s IPO.
A portion of the proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO deposited in the Issuer’s SPAC trust account (the “Trust Account”). If the Issuer does not complete an initial business combination within the period (the “Combination Period”) allowed by Issuer’s Current Charter (as defined below), the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable for cash and exercisable on a cashless basis so long as they are held by the initial purchasers or their permitted transferees.
Pursuant to Letter Agreements (as defined below), each of the Sponsor, Mr. Lebensohn and Mr. Freedman, among others, agreed to waive (i) their redemption rights with respect to their shares of Class B Common Stock and any public shares held by them in connection with the completion of the Issuer’s initial business combination; (ii) their redemption rights with respect to their shares of Class B Common Stock and any public shares held by them in connection with a stockholder vote to approve an amendment to the Issuer’s amended and restated certificate of incorporation to modify the substance or timing of the Issuer’s obligation to allow redemption in connection with the Issuer’s initial business combination or to redeem 100% of the Issuer’s public shares if the Issuer has not completed an initial business combination within the prescribed time periods; and (iii) their rights to liquidating distributions from the Trust Account with respect to any shares of Class B Common Stock held by them if the Issuer does not complete the Issuer’s initial business combination within the prescribed time periods.
In addition, pursuant to such Letter Agreements, the Sponsor (and each of the Issuer’s directors and executive officers, including Messrs. Lebensohn and Freedman) have agreed not to transfer, assign or sell any of their shares of Class B Common Stock (or any shares of Class A
Common Stock issued or issuable upon conversion of the Class B Common Stock) until the earlier to occur of (a) one year after the completion of the Issuer’s initial business combination, or (b) subsequent to the Issuer’s initial business combination, (x) if the last reported sale price of the Issuer’s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the consummation of the Issuer’s initial business combination, or (y) the date on which the Issuer completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Issuer’s public stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor with respect to any such shares of common stock.